These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32185705)

  • 1. Molecular and Cellular Functions of CTLA-4.
    Van Coillie S; Wiernicki B; Xu J
    Adv Exp Med Biol; 2020; 1248():7-32. PubMed ID: 32185705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.
    Qureshi OS; Zheng Y; Nakamura K; Attridge K; Manzotti C; Schmidt EM; Baker J; Jeffery LE; Kaur S; Briggs Z; Hou TZ; Futter CE; Anderson G; Walker LS; Sansom DM
    Science; 2011 Apr; 332(6029):600-3. PubMed ID: 21474713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
    Holt MP; Punkosdy GA; Glass DD; Shevach EM
    J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
    Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement.
    Wang CJ; Heuts F; Ovcinnikovs V; Wardzinski L; Bowers C; Schmidt EM; Kogimtzis A; Kenefeck R; Sansom DM; Walker LS
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):524-9. PubMed ID: 25548162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.
    Soskic B; Jeffery LE; Kennedy A; Gardner DH; Hou TZ; Halliday N; Williams C; Janman D; Rowshanravan B; Hirschfield GM; Sansom DM
    Front Immunol; 2020; 11():577655. PubMed ID: 33488578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
    Halliday N; Williams C; Kennedy A; Waters E; Pesenacker AM; Soskic B; Hinze C; Hou TZ; Rowshanravan B; Janman D; Walker LSK; Sansom DM
    Front Immunol; 2020; 11():600000. PubMed ID: 33363541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance.
    Romo-Tena J; Gómez-Martín D; Alcocer-Varela J
    Autoimmun Rev; 2013 Oct; 12(12):1171-6. PubMed ID: 23851140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
    Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tasmanian devil CD28 and CTLA4 capture CD80 and CD86 from adjacent cells.
    Wong C; Darby JM; Murphy PR; Pinfold TL; Lennard PR; Woods GM; Lyons AB; Flies AS
    Dev Comp Immunol; 2021 Feb; 115():103882. PubMed ID: 33039410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transendocytosis perspective on the CD28/CTLA-4 pathway.
    Soskic B; Qureshi OS; Hou T; Sansom DM
    Adv Immunol; 2014; 124():95-136. PubMed ID: 25175774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.
    Zhao Y; Lee CK; Lin CH; Gassen RB; Xu X; Huang Z; Xiao C; Bonorino C; Lu LF; Bui JD; Hui E
    Immunity; 2019 Dec; 51(6):1059-1073.e9. PubMed ID: 31757674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
    Kennedy A; Waters E; Rowshanravan B; Hinze C; Williams C; Janman D; Fox TA; Booth C; Pesenacker AM; Halliday N; Soskic B; Kaur S; Qureshi OS; Morris EC; Ikemizu S; Paluch C; Huo J; Davis SJ; Boucrot E; Walker LSK; Sansom DM
    Nat Immunol; 2022 Sep; 23(9):1365-1378. PubMed ID: 35999394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
    Panda AK; Kim YH; Shevach EM
    J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting B7-1 in immunotherapy.
    Chen R; Ganesan A; Okoye I; Arutyunova E; Elahi S; Lemieux MJ; Barakat K
    Med Res Rev; 2020 Mar; 40(2):654-682. PubMed ID: 31448437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.